Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,407 across all filing types
Latest filing 2025-08-21 Major Shareholding Noti…
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by AstraZeneca PLC. It details the acquisition or disposal of voting rights by The Capital Group Companies, Inc., specifically noting that the threshold for major shareholding has been crossed. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2025-08-21 English
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 100% confidence The document is a 'flaggningsmeddelande' (flagging notification) filed with the Swedish Financial Supervisory Authority (Finansinspektionen). It details a change in shareholding by The Capital Group Companies, Inc. in AstraZeneca PLC, specifically noting that their ownership has dropped below the 5% threshold. This is a classic major shareholding notification, which corresponds to the MRQ filing category.
2025-08-21 Swedish
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2025-08-18 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of a share transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically the Chief Financial Officer of AstraZeneca PLC. It details the sale of ordinary shares, including the price, volume, and date of the transaction, in compliance with the EU Market Abuse Regulation. This falls directly under the definition of 'Director's Dealing' (DIRS).
2025-08-18 English
HOLDING(S) IN COMPANY
Regulatory Filings
2025-08-15 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by AstraZeneca PLC. It explicitly details the acquisition of voting rights by The Capital Group Companies, Inc., crossing the 5% threshold. This fits the definition of a Major Shareholding Notification (MRQ), which tracks changes in significant share ownership levels.
2025-08-15 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.